A Study of Evacetrapib in Healthy Japanese Participants
NCT02226653
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Evacetrapib
Sponsor
Eli Lilly and Company